AIDS vaccine trials may have added risk

Mar 21, 2008

Two field tests of an AIDS vaccine not only failed to protect people from the virus but may have put them at greater risk, U.S. researchers said.

The results of the worldwide trials prompted scientific inquiry as researchers try to assess what happened and whether they should known the outcome, The Washington Post reported Friday.

Both field tests were halted in September and seven other trials of similarly designed AIDS vaccines have been stopped or postponed indefinitely.

"This is on the same level of catastrophe as the (NASA space shuttle) Challenger disaster," said Robert Gallo, co-discoverer of the human immunodeficiency virus, the virus that causes AIDS, and head of the Institute for Human Virology in Baltimore.

The STEP and Phambili studies used the same vaccine and were stopped when it became evident the studies were futile and possibly harmful, the Post reported.

One hypothesis for what went wrong is the vaccine somehow prepared the immune system to be more susceptible to HIV infection, a scenario that wasn't foreseen or suggested by previous studies, the Post said.

The National Institutes of Health in Bethesda, Md, which funded the trials, will meet week to reassess its AIDS vaccine program.

Copyright 2008 by United Press International

Explore further: Bacterial communities of female genital tract have impact on inflammation, HIV risk

Related Stories

Spanish doctors unveil promising AIDS vaccine

Feb 01, 2011

Spanish researchers announced Tuesday they have developed an AIDS vaccine which cuts the viral load by a significant amount in most patients although they cautioned it is still not enough as a treatment.

Recommended for you

HIV reservoirs remain obstacles to cure

May 19, 2015

Antiretroviral therapy (ART) has proven lifesaving for people infected with HIV; however, the medications are a lifelong necessity for most HIV-infected individuals and present practical, logistical, economic ...

Microclinics help keep Kenyan HIV patients in care

May 18, 2015

A team led by researchers from UC San Francisco, Organic Health Response, and Microclinic International is reporting results of a study that showed significant benefits of microclinics—an innovative intervention ...

'Redesigned' antibodies may control HIV

May 18, 2015

With the help of a computer program called "Rosetta," researchers at Vanderbilt University have "redesigned" an antibody that has increased potency and can neutralize more strains of the AIDS-causing human ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

herpesdate
not rated yet Mar 21, 2008
good info. HIV People at www.HerpesFinder.com may like it

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.